Pharmaceutical Investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
Biotech Investing Arch Biopartners Completes Pre-IND Meeting with U.S. FDA on LSALT Peptide for Preventing Acute Kidney Injury in Cardiac Surgery Patients
Pharmaceutical Investing Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin
Pharmaceutical Investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Pharmaceutical Investing VistaGen Therapeutics Receives European Patent regarding Methods of Production for AV-101
Pharmaceutical Investing Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
Biotech Investing Arch Biopartners Announces Issuance of U.S. Patent for Its Novel Antibacterial Drug AB569
Pharmaceutical Investing Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery
Pharmaceutical Investing Proteostasis Therapeutics Announces FDA Grants Orphan Drug Designation for PTI-428 in Cystic Fibrosis